Dr. Bogdana Schmidt, MD
Urology (Urology Physician)
300 Pasteur Dr
Stanford, CA 94305
Who else practices at this address →
Santa Clara County includes mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 187
Licensed in California since 2014, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
CA license A133342 (first issued 2014; delinquent)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Utah Hospital and Clinics Salt Lake City, UT
- Portneuf Medical Center Pocatello, ID
- Memorial Hospital Sweetwater County Rock Springs, WY
- Northeastern Nevada Regional Hospital Elko, NV
Medical groups
- University of Utah Adult Services (1,788 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 187
- Services billed
- 495
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 78 | 62 |
| Diagnostic exam of bladder and urethra using an endoscope | 46 | 28 |
| New patient office or other outpatient visit, 60-74 minutes | 43 | 43 |
| Established patient office or other outpatient visit, 40-54 minutes | 40 | 39 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Stanford, CA | 23 |
| Myrbetriq (mirabegron) Other prescribers in Stanford, CA | 16 |
| Oxybutynin Chloride Other prescribers in Stanford, CA | 14 |
| Eliquis (apixaban) Other prescribers in Stanford, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 27 payments worth $18,348 in total to this clinician.
| Ferring Pharmaceuticals Inc. | $11,534 |
|---|---|
| Janssen Global Services, LLC | $3,084 |
| Intuitive Surgical, Inc. | $1,659 |
| Janssen Scientific Affairs, LLC | $1,031 |
| Janssen Biotech, Inc. | $965 |
| Coloplast Corp | $75.58 |
| Consulting Fee | $15,598 |
|---|---|
| Education | $1,500 |
| Food and Beverage | $1,134 |
| Travel and Lodging | $117 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. Dec 22, 2025 | Consulting Fee ADSTILADRIN · ONCOLOGY | $8,075 |
| Ferring Pharmaceuticals Inc. Nov 14, 2025 | Consulting Fee ADSTILADRIN · ONCOLOGY | $2,850 |
| Janssen Global Services, LLC Dec 5, 2025 | Consulting Fee | $2,538 |
| Intuitive Surgical, Inc. Jan 17, 2025 | Education DA VINCI SP · SURGERY · in-kind | $1,500 |
| Janssen Biotech, Inc. Apr 27, 2025 | Consulting Fee | $818 |
| Janssen Scientific Affairs, LLC Apr 27, 2025 | Consulting Fee | $818 |
| Janssen Global Services, LLC Apr 16, 2025 | Consulting Fee | $500 |
| Ferring Pharmaceuticals Inc. Dec 13, 2025 | Travel and Lodging ADSTILADRIN · ONCOLOGY · travel to SALT LAKE CITY, UT · in-kind | $117 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $106,991 in research payments for these studies, mostly to the institutions running them.
- A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4)
Janssen Research & Development, LLC - ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Ferring Pharmaceuticals As · Terminated · NCT06026332 - A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination with Cetrelimab Versus Intravesical Bacillus CalmetteGurin (BCG) in Participants with BCG-nave High-Ri…
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.